2708-77-2NC(CC(F)C(=O)O)C(=O)OJPSHPWJJSVEEAX-UHFFFAOYSA-NRN given refers to cpd without isomeric designation
2708-77-2Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (97.5%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden4-Fluoro-DL-glutamic acid is used as a reagent to synthesize analogues of Methotrexate (M260675), a drug that is used to treat acute leukemia, breast carcinoma, and rheumatoid arthritis. The labelled form of 4-Fluoro-DL-glutamic acid is used in the medical field as an amino acid radiotracer for imaging of tumours.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
DTXSID40949843CHEMBL5308377